McKesson
McKesson Corporation is an American healthcare infrastructure enterprise that engages in pharmaceutical wholesale distribution, medical supply chain management, and health technology services. The company organizes its business operations across four primary reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. Its product and service portfolio encompasses wholesale distribution of branded, generic, and specialty pharmaceuticals, medical-surgical supplies, plasma products, oncology logistics, and pharmacy software. Principal revenue drivers consist of high-volume wholesale drug distribution contracts with major retail pharmacy networks, independent pharmacies, and institutional healthcare facilities. McKesson serves diverse global end markets comprising retail pharmacy chains, hospital systems, physician clinics, ambulatory surgery centers, and pharmaceutical manufacturing partners. The enterprise maintains a market-leading global position as one of the top wholesale pharmaceutical distributors in North America, processing a substantial share of all prescription medicines sold in the United States. Headquartered in Irving, Texas, the company's common stock is publicly traded on the New York Stock Exchange under the ticker symbol MCK and is included in the Fortune 500 and S&P 500 indices.
124 of the funds FundTelligence covers report a position in McKesson.
- Legal name
- McKesson Corp.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 124
Funds holding McKesson
- Invesco Social Progress Fund — Invesco · 4.0 % (largest positions only, June 2026)
- Janus Henderson Horizon Us Sustainable Equity Fund — Janus Henderson · 3.59 % (largest positions only, September 2026)
- Invesco Global Health Care Innovation Fund — Invesco · 3.5 % (largest positions only, April 2026)
- Fondsfinans Global Helse — Fondsfinans · 3.45 % (full portfolio disclosed, October 2026)
- Janus Henderson Horizon Global Sustainable Equity Fund — Janus Henderson · 2.99 % (largest positions only, September 2026)
- Fondsfinans Global Utbytte — Fondsfinans · 2.98 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Selektiv — Handelsbanken · 2.92 % (full portfolio disclosed, October 2026)
- Swedbank Robur Healthcare — Swedbank · 2.81 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 124 funds holding it.